Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > TKNO Alpha Teknova > Key Indicators
TKNO Alpha Teknova
4.570
-0.010-0.22%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
57.96% 104.452 58.43% 105.2154 25.90% 85.5114 3.99% 94.1794
Receivable Turnover(T)
6.22% 8.6081 -4.68% 8.5811 -6.19% 7.6584 -12.74% 7.9434
Inventory Turnover(T)
-25.63% 3.1637 -15.35% 3.8173 4.70% 4.079 -2.52% 4.2941
Fixed Assets Turnover(T)
-43.35% 0.9321 -49.87% 0.9993 -56.21% 1.1093 -54.24% 1.8531
Total Asset Rate(T)
21.32% 0.2649 12.75% 0.2387 -33.47% 0.2995 -37.61% 0.3216
ROIC
-1,152.27% -24.538% -4,419.02% -11.173% -250.88% -14.600% -145.19% -10.672%
ROE
-1,283.07% -29.293% -4,817.52% -13.167% -211.88% -18.917% -150.94% -12.256%
ROA
-1,154.16% -22.961% -4,448.73% -10.485% -411.13% -11.257% -245.33% -8.546%
Efficiency Ratios
Profitability Ratios TTM
Gross Margin
-5.43% 46.621% -10.08% 46.855% -17.60% 46.058% -15.81% 47.762%
Operating Margin
-209.61% -54.027% -4,378.07% -49.890% -630.29% -43.691% -318.46% -32.548%
Net Margin
-933.74% -86.668% -3,957.59% -43.926% -567.64% -37.588% -332.94% -26.571%
EBITDA Margin
-360.18% -0.4703% -856.73% -0.4263% -343.74% -0.3604% -215.42% -0.2473%
R & D Expense Ratio
80.56% 16.630% 142.20% 15.840% 163.02% 14.440% 142.53% 11.690%
Sales Expense Ratio
99.89% 18.050% 82.62% 15.030% 58.89% 11.980% 43.82% 10.240%
Administration Expense Rate
39.52% 63.340% 78.90% 63.170% 93.09% 60.380% 110.71% 55.270%
Financial Health Ratios
Long-Term Debt to Equity Ratio
272.15% 30.098% 224.40% 25.645% -70.09% 21.548% -- 8.289%
Total Assets to Common Equity
23.70% 143.105% 17.90% 136.509% -71.57% 132.867% -69.01% 116.276%
Debt to Asset Ratio
297.02% 32.109% 245.19% 27.289% -67.99% 23.062% -- 8.289%
Current Ratio
-68.26% 5.6836 -66.03% 6.7654 68.00% 7.2759 215.49% 13.0704
Quick Ratio
-72.73% 4.5606 -68.89% 5.9554 99.02% 6.6177 308.53% 12.0589
GrowthRatios
Growth Ratios
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Alpha Teknova, Inc. engages in the manufacture of cell culture media and supplements. It provides reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. The company was founded by Thomas E. Davis in 1996 and is headquartered in Hollister, CA.
CEO: Mr. Stephen Gunstream
Market: NASDAQ
Listing Date: 06/25/2021
Futu Hot List
USHKCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist